Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,573 signal articles · 139 in last 24h · 155,079 total before filter · latest 43m ago
139last 24h
842last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro185Earnings100M&A125Regulatory20Product21Analyst19
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Bloomberg56d agobullish
Sleep-Apnea Biotech Apnimed Shares Jump After Upsized US IPO

(Bloomberg) -- Apnimed Inc., a late-stage drug developer focused on sleep apnea rose 6.3% on Friday after raising $192 million in an upsized US initial public offering.Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesAnthropic AI Models Hacked Three Organizations During TestsMicrosoft’s $450 Billion Jump Is Biggest in Stock Market HistoryChip Stocks Post Biggest Advance Since April 2025: Markets WrapUS Strikes Iran Again as Conflict Spreads Across Middle Ea

Top nuclear power firm files for US IPO
InvestorsHub56d agoneutral
Top nuclear power firm files for US IPO

Nuclear power pioneer Westinghouse Electric Company has taken the initial step toward going public by submitting a confidential Form S-1 draft registration statement to the U. S.

Rivian Stock Down 87% Since IPO
24/7 Wall St.56d agoneutral
Rivian Stock Down 87% Since IPO

Rivian (NASDAQ: RIVN), the troubled EV company, went public on November 10, 2021. After a good deal of excitement, the stock is down 87% since then. Whatever hope new Q2 unit sales brought, the company is still on the ropes and is unlikely to get off them. Rivian just announced it delivered 12,194 vehicles to ... Rivian Stock Down 87% Since IPO